ClinVar Miner

Submissions for variant NM_003784.4(SERPINB7):c.796C>T (p.Arg266Ter)

gnomAD frequency: 0.00019  dbSNP: rs142859678
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000479535 SCV000567359 pathogenic not provided 2022-08-11 criteria provided, single submitter clinical testing Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 115 amino acids are lost, and other loss-of-function variants have been reported in the Human Gene Mutation Database (HGMD); This variant is associated with the following publications: (PMID: 24514002, 27786350, 27663160, 27569382, 27543371, 27506501, 28211129, 29888704, 30256384, 30581033, 30833958, 30004585, 32406097, 31980526, 24077912, 34426522, 33362511, 32892407, 33914963, 34379845, 27666198, 24207119, 24773080)
Fulgent Genetics, Fulgent Genetics RCV000088682 SCV000894164 pathogenic Palmoplantar keratoderma, Nagashima type 2018-10-31 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000479535 SCV001247832 pathogenic not provided 2018-05-01 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000088682 SCV002020073 pathogenic Palmoplantar keratoderma, Nagashima type 2021-03-14 criteria provided, single submitter clinical testing
3billion RCV000088682 SCV002058138 pathogenic Palmoplantar keratoderma, Nagashima type 2023-12-27 criteria provided, single submitter clinical testing The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.053%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000102446 /PMID: 24207119 /3billion dataset). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Genetics and Molecular Pathology, SA Pathology RCV000088682 SCV002761696 pathogenic Palmoplantar keratoderma, Nagashima type 2021-12-08 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000479535 SCV003283223 pathogenic not provided 2024-12-12 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg266*) in the SERPINB7 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 115 amino acid(s) of the SERPINB7 protein. This variant is present in population databases (rs142859678, gnomAD 0.7%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individual(s) with Nagashima-type palmoplantar keratoderma (NPPK) (PMID: 24207119, 24514002, 27543371, 27666198). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It is commonly reported in individuals of Japanese and Han Chinese ancestry (PMID: 24514002, 24773080). ClinVar contains an entry for this variant (Variation ID: 102446). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic.
PreventionGenetics, part of Exact Sciences RCV003415873 SCV004108780 pathogenic SERPINB7-related disorder 2023-03-08 criteria provided, single submitter clinical testing The SERPINB7 c.796C>T variant is predicted to result in premature protein termination (p.Arg266*). This variant has been reported to be causative for autosomal recessive Nagashima-type palmoplantar keratosis and has been described as a founder mutation in Asian populations (Kubo et al. 2013. PubMed ID: 24207119; Yin et al. 2014. PubMed ID: 24514002; Zhang et al. 2016. PubMed ID: 27666198). This variant is reported in 0.69% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/18-61471522-C-T). Nonsense variants in SERPINB7 are expected to be pathogenic. This variant is interpreted as pathogenic.
Molecular Genetics, Royal Melbourne Hospital RCV000088682 SCV004812579 pathogenic Palmoplantar keratoderma, Nagashima type 2024-03-01 criteria provided, single submitter clinical testing This sequence change in SERPINB7 is a nonsense variant predicted to cause a premature stop codon, p.(Arg266*), that is predicted to escape nonsense-mediated decay and remove <10% of the protein (removes amino acids 226-380) in a gene where loss of function is an established disease mechanism. The highest population minor allele frequency in the population database gnomAD v4.0 is 0.8% (347/44,860 alleles) in the East Asian population, which is higher than expected for a recessive disease. However, this variant is an East Asian founder mutation for Nagashima-type palmoplantar keratoderma. It has been reported in multiple affected individuals in the homozygous and compound heterozygous state (with at least one individual with a pathogenic variant on the second allele) and segregates with disease in at least one family (PMID: 24207119, 35178744). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as PATHOGENIC. Following criteria are met: PM3_VeryStrong, PVS1_Strong, PP1, BS1.
Juno Genomics, Hangzhou Juno Genomics, Inc RCV000088682 SCV005417605 pathogenic Palmoplantar keratoderma, Nagashima type criteria provided, single submitter clinical testing PM3_VeryStrong+PVS1_Strong
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000088682 SCV005914891 pathogenic Palmoplantar keratoderma, Nagashima type 2023-03-24 criteria provided, single submitter research
OMIM RCV000088682 SCV000121604 pathogenic Palmoplantar keratoderma, Nagashima type 2014-10-01 no assertion criteria provided literature only
Reproductive Health Research and Development, BGI Genomics RCV000088682 SCV001142482 pathogenic Palmoplantar keratoderma, Nagashima type 2020-01-06 no assertion criteria provided curation NM_003784.3:c.796C>T in the SERPINB7 gene has an allele frequency of 0.007 Asia in East Asian subpopulation in the gnomAD database. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. It was detected in individual with autosomal recessive Palmoplantar keratoderma, nagashima type, compound heterozygous with c.218_219del2ins12, c.455-1G>A, respectively (PMID: 24207119). Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP criteria applied: PVS1; PM3_Strong; PP4.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.